Nucleus Research Releases the Value Matrix for Analytics

May 23, 2011

IBM scores the highest in delivering customer value, followed by Microsoft and Oracle

 

BOSTON – May 24, 2011 – Nucleus Research today released the 1H2011 Technology Value Matrix for Analytics. The Value Matrix evaluates analytics applications for their ability to deliver value to customers based on functionality and usability – two core factors that Nucleus has found indicate an application’s ability to drive both initial time to value and ongoing return on investment (ROI).

IBM scored the highest on the Matrix exceeding all other vendors in both functionality and usability. Microsoft and Oracle also scored high on the Value Matrix. The Matrix also includes vendors with non-traditional approaches that enable faster and less expensive adoption of analytics through cloud delivery and the ability to deploy without a data cube, long a mainstay of traditional analytics.

“Analytics continues to be a hotly contested market and recent Nucleus Research ROI case studies have shown that a number of vendors deliver significant value. We expect continued investment in analytics” said David O’Connell, senior analyst, Nucleus Research. “We also anticipate continued industry consolidation as smaller vendors find it harder to compete against leading vendors that have both extensive product offerings and the ability to help organizations deploy analytics enterprisewide.”

Organizations can use the Value Matrix to assess their analytics investment short list as well as to evaluate the case for maintaining an existing solution that may lag behind the value offered by other options. Nucleus Research produces Value Matrix reports in major enterprise software categories every six months. To read the Value Matrix report, go to NucleusResearch.com.

About Nucleus Research

Nucleus Research is a global provider of investigative, case-based technology research and advisory services that provide real-world insight into maximizing technology value. For more information, visit NucleusResearch.com.